18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia

Fidel J Vos1, Chantal P Bleeker-Rovers, Patrick D Sturm

  • 1Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. f.vos@aig.umcn.nl

Abstract

Insights

Early detection of metastatic foci in gram-positive bacteremia using 18F-FDG PET/CT significantly reduces mortality rates. This imaging technique improves diagnosis and outcomes for high-risk patients, particularly those with Staphylococcus aureus infections.

Area of Science:

  • Nuclear Medicine
  • Infectious Diseases
  • Radiology

Background:

  • Metastatic infectious foci in gram-positive bacteremia are challenging to detect due to absent localizing symptoms.
  • Timely diagnosis is crucial as these foci often necessitate prolonged treatment or drainage.

Purpose of the Study:

  • To investigate the efficacy of 18F-FDG PET/CT in detecting metastatic infectious foci in patients with gram-positive bacteremia.
  • To determine if the use of 18F-FDG PET/CT influences clinical outcomes, including mortality and relapse rates.

Main Methods:

  • Prospective inclusion of 115 nonneutropenic patients with gram-positive bacteremia (Staphylococcus aureus, Streptococcus, Enterococcus species) and risk factors for metastatic foci.
  • 18F-FDG PET/CT performed within 2 weeks of positive blood cultures, with abnormal uptake confirmed by other diagnostic methods.
  • Comparison with a historical control group of 230 patients who did not undergo 18F-FDG PET/CT.

Main Results:

  • Significantly higher diagnosis rates of metastatic foci in the study group (67.8%) compared to the control group (35.7%).
  • 18F-FDG PET/CT was the primary imaging modality for detecting infectious foci in 30% of patients.
  • Reduced relapse rates (7.4% to 2.6%) and a significant decrease in overall 6-month mortality (32.2% to 19.1%) in the 18F-FDG PET/CT group.

Conclusions:

  • 18F-FDG PET/CT is a valuable diagnostic tool for high-risk patients with gram-positive bacteremia, leading to improved clinical outcomes and reduced mortality.
  • The addition of 18F-FDG PET/CT significantly decreased relapse rates in patients with Staphylococcus aureus bacteremia.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...